INVA
INVA
NASDAQ · Pharmaceuticals

Innoviva Inc

$19.24
-2.02 (-9.50%)
As of Nov 7, 1:48 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 1 9%
Sell 1 9%
Price Target
Analyst Price Target +103.5% upside
Low Target $23.99
Average Target $39.16
High Target $41.33
Current Price $19.24
Current
$19.24
Target
$39.16
$23.99 $39.16 avg $41.33
Scenario Analysis
Bear Case
$23.99
24.7%
Low target
Base Case
$39.16
+103.5%
Avg target
Bull Case
$41.33
+114.8%
High target
Risk/Reward
4.7x
Highly favorable
Price in Context
52-Week High
$25.15
-23.5% from high
52-Week Low
$17.87
+7.7% from low
Target vs 52W High
$39.16
+55.7% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $0.53
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%